Upgrade to SI Premium - Free Trial

Piper Jaffray Starts Sage Therapeutics (SAGE ) at Overweight

August 6, 2018 5:34 AM
Piper Jaffray initiates coverage on Sage Therapeutics (NASDAQ: SAGE ) with a Overweight rating and a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot New Coverage New Coverage

Next Articles